Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Coles

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Mayo Clinic Proceedings|November 1, 1993
ThymomaT I Morgenthaler, L R Brown, T V Colby, et al.
Cancer Treatment Reports|January 1, 1977
Phase II studies of polychemotherapy regimens in small cell lung cancerR T Eagan, D T Carr, R E Lee, et al.
American Journal of Clinical Oncology|June 1, 1986
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAPR T Eagan, S Frytak, E T Creagan, et al.
Cancer Treatment Reports|September 1, 1979
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lungR T Eagan, S Frytak, E T Creagan, et al.
Mayo Clinic Proceedings|January 1, 1991
Roentgenologic features of pulmonary blastomycosisL R Brown, S J Swensen, R E Van Scoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1981
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
Cancer Treatment Reports|November 1, 1981
Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Cancer Treatment Reports|October 1, 1977
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancerR T Eagan, J N Ingle, S Frytak, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Mayo Clinic Proceedings|November 1, 1993
ThymomaT I Morgenthaler, L R Brown, T V Colby, et al.
Cancer Treatment Reports|January 1, 1977
Phase II studies of polychemotherapy regimens in small cell lung cancerR T Eagan, D T Carr, R E Lee, et al.
American Journal of Clinical Oncology|June 1, 1986
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAPR T Eagan, S Frytak, E T Creagan, et al.
Cancer Treatment Reports|September 1, 1979
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lungR T Eagan, S Frytak, E T Creagan, et al.
Mayo Clinic Proceedings|January 1, 1991
Roentgenologic features of pulmonary blastomycosisL R Brown, S J Swensen, R E Van Scoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|July 1, 1981
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
Cancer Treatment Reports|November 1, 1981
Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Cancer Treatment Reports|October 1, 1977
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancerR T Eagan, J N Ingle, S Frytak, et al.
Pageof 3